Coping and living with chronic pain in persons with spinal cord injury: daily life participation and quality of life.
- Conditions
- Chronische pijnChronic painSpinal Cord Injury10041543
- Registration Number
- NL-OMON56375
- Lead Sponsor
- Adelante Zorggroep
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Patients with Spinal Cord Injury (SCI) longer than 6 months; Patients with the
age of 18 years and older; Patients who suffer from SCI related chronic pain,
as classified by the International Spinal Cord Injury Pain (ISCIP)
classification; Patients where there is a willingness to address and change
biopsychosocial factors that are related to daily life functioning despite the
pain
Patients who experience severe pain due to other diseases (e.g., neuropathies,
cancer, vascular problems)
Patients who have received a biopsychosocial rehabilitation treatment or any
other form of cognitive behavioural therapy within the past 6 months will be
excluded from this study.
Patients who have insufficient comprehension of Dutch language
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Disability: Pain Disability Index (PDI). This 7-item questionnaire investigates<br /><br>the magnitude of self-reported disability in different domains, e.g., work,<br /><br>leisure time, activities of daily living (ADL) and sports.<br /><br><br /><br>Quality of Live: The EuroQoL EQ-5D is a brief self-reported generic measure of<br /><br>current health that consists of five dimensions (mobility, self-care, usual<br /><br>activities, pain/discomfort, and anxiety/depression). </p><br>
- Secondary Outcome Measures
Name Time Method <p>SCI-related complications (SCI-SCS)<br /><br>Anxiety and Depression (HADS)<br /><br>Pain-related fear (PASS-20)<br /><br>Pain Interference (MPI-SCI)<br /><br>Acceptance (AAQ-II-P)<br /><br>Psychological inflexibility (PIPS)<br /><br>Self-efficacy (UW-SES 6)</p><br>